FIELD: medicine, ophthalmology, pharmacy. SUBSTANCE: composition has para-aminobenzoic acid and pharmaceutically acceptable additions at mass ratio = (0.00007-0.007):1, respectively. Composition has NaCl solution, boric acid and laevomycetin solution, boric acid solution and others as additions. Composition can be liquid for drop, injection and external using or an ointment. Composition has small amount of para-aminobenzoic acid that ensures to use its in ophthalmology. EFFECT: enhanced effectiveness of composition. 10 cl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF VIRAL DISEASES CAUSED BY HERPES VIRUS | 1993 |
|
RU2068691C1 |
| INTERFERON INDUCING AGENT | 1998 |
|
RU2132681C1 |
| OPHTHALMIC OINTMENT FORMULATION AND METHOD FOR PREPARING SAME | 2012 |
|
RU2531937C2 |
| METHOD OF TREATMENT OF PROGRESSIVE PTERYGIUM | 0 |
|
SU1248602A1 |
| OINTMENT TYPE PANPHARMACON FOR COMPLEX TREATMENT OF ANIMAL EYE DISEASES AND METHOD OF PRODUCING THEREOF | 2017 |
|
RU2667118C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BURN (VARIANTS) AND METHOD FOR ITS PREPARING (VARIANTS) | 2006 |
|
RU2317811C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
| JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS | 2013 |
|
RU2533274C1 |
| PHARMACEUTICAL ANTI-HERPETIC COMPOSITION | 2004 |
|
RU2291690C2 |
| METHOD FOR DRY EYE SYNDROME TREATMENT IN PATIENTS WITH DIABETES MELLITUS | 2020 |
|
RU2749984C1 |
